NCT00231257View on ClinicalTrials.gov

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

PHASE3CompletedINTERVENTIONAL

Enrollment

384

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

January 31, 2005

Study Completion Date

September 30, 2009

Conditions

In-Stent Restenosis

Interventions

DEVICE

Sirolimus-Eluting Bx Velocity® Balloon Expandable Stent

Sirolimus-Eluting Bx Velocity® Balloon Expandable Stent

PROCEDURE

Brachytherapy

Brachytherapy

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

Cordis Corporation

All Listed Sponsors

lead

Cordis Corporation

INDUSTRY